A joint venture
GSK Consumer Healthcare has closed its transaction with Pfizer Consumer Healthcare in the UK and Ireland, creating a new joint venture under the name GSK Consumer Healthcare, the company has announced.
Since its launch on 27 April 2020, the new business has been working to bring together the two legacy teams and establish GSK Consumer Healthcare as a single operational entity. It aims to deliver global leadership across a broad spectrum of therapeutic areas and establish a strong combined OTC portfolio for customers, including brands such as Sensodyne, Voltarol, Panadol, Corsodyl, Anadin, Centrum and Nexium.
Commenting on the joint venture, area general manager Jon Workman said: “We are embarking on a long-term self care movement with the aim of sustaining a shift in the behaviours of the nation – getting people to think pharmacist first and avoid unnecessary visits to the GP and A&E in the longer term.”
GSK Health Partner
Common feeding feeding issues, including coloc, reflux and regurgitation, and some of the ways they can be managed
Upgrade your contraceptive consultations by exploring the interactive pack to learn about a daily oral contraceptive pill
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
Priadel manufacturer walked away from pricing talks claims DH
The DHSC has told Pharmacy Network News it is disappointed at Essential Pharma’s decision to exit talks on Priadel 200mg and 400mg tablets.
1 Min Article
Pay concerns 'driving retention issues in pharmacy'
Concerns around pay and workload are partly behind growing retention issues among the community pharmacy workforce, a new report warns.
1 Min Article
Advising customers of a unique formulation for a blocked and runny nose from colds
Understand the differences between topical medication for nasal symptoms of the common cold, and topical medication for ongoing nasal problems
25 Min Module